Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Operating Expenses (2016 - 2026)

Biomerica's Operating Expenses history spans 17 years, with the latest figure at $1.3 million for Q1 2026.

  • Quarterly results put Operating Expenses at $1.3 million for Q1 2026, up 2.03% from a year ago — trailing twelve months through Feb 2026 was $5.5 million (down 5.53% YoY), and the annual figure for FY2025 was $5.6 million, down 19.25%.
  • Operating Expenses for Q1 2026 was $1.3 million at Biomerica, down from $1.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.4 million in Q2 2022 to a low of $1.2 million in Q1 2025.
  • The 5-year median for Operating Expenses is $1.7 million (2024), against an average of $1.7 million.
  • The sharpest move saw Operating Expenses surged 38.83% in 2022, then tumbled 33.6% in 2025.
  • Year by year, Operating Expenses stood at $2.0 million in 2022, then decreased by 4.21% to $1.9 million in 2023, then fell by 26.02% to $1.4 million in 2024, then dropped by 0.42% to $1.4 million in 2025, then dropped by 11.94% to $1.3 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $1.3 million, $1.4 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.